HU308, A Selective Cannabinoid Type-2 Receptor Agonist, Mitigates SARS-CoV-2 Spike Protein–Induced Acute Lung Injury in MiceJ. Lockett(Eastern Virginia Medical School), Nagaraja N. Nagre(Eastern Virginia Medical School)LungFebruary 9, 202610.1007/s00408-026-00870-6Cited by 0SaveCiteExport RISWatch citationsRelated PapersActivation of cannabinoid-2 receptor protects against Pseudomonas aeruginosa induced acute lung injury and inflammation|Respiratory Research|2022|17Cannabinoid-2 Receptor Activation Attenuates Sulfur Mustard Analog 2-Chloroethyl-Ethyl-Sulfide-Induced Acute Lung Injury in Mice|Pharmaceuticals|2025|3